Theravance Biopharma Inc
NASDAQ:TBPH
Income Statement
Earnings Waterfall
Theravance Biopharma Inc
Revenue
|
57.4m
USD
|
Operating Expenses
|
-110.7m
USD
|
Operating Income
|
-53.3m
USD
|
Other Expenses
|
-1.9m
USD
|
Net Income
|
-55.2m
USD
|
Income Statement
Theravance Biopharma Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
1
+450%
|
4
+273%
|
10
+154%
|
12
+13%
|
31
+166%
|
35
+13%
|
40
+13%
|
42
+6%
|
40
-5%
|
39
-4%
|
47
+22%
|
49
+4%
|
33
-31%
|
31
-6%
|
17
-47%
|
15
-7%
|
21
+34%
|
41
+97%
|
49
+21%
|
60
+23%
|
57
-5%
|
60
+5%
|
60
-1%
|
73
+23%
|
88
+20%
|
77
-13%
|
83
+8%
|
72
-13%
|
66
-8%
|
64
-3%
|
59
-8%
|
55
-6%
|
54
-2%
|
52
-3%
|
52
-1%
|
51
-1%
|
49
-5%
|
51
+5%
|
54
+6%
|
57
+6%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
(0)
|
(1)
|
(1)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(5)
|
(3)
|
(3)
|
(3)
|
(4)
|
(6)
|
(6)
|
(4)
|
(3)
|
(1)
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
1
N/A
|
4
+338%
|
10
+171%
|
8
-20%
|
27
+254%
|
31
+14%
|
35
+13%
|
38
+7%
|
35
-7%
|
33
-5%
|
42
+26%
|
46
+10%
|
31
-33%
|
28
-9%
|
12
-55%
|
9
-24%
|
14
+52%
|
37
+159%
|
46
+24%
|
60
+30%
|
57
-4%
|
0
N/A
|
33
N/A
|
73
+124%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(157)
|
(185)
|
(205)
|
(220)
|
(240)
|
(237)
|
(230)
|
(228)
|
(219)
|
(221)
|
(221)
|
(221)
|
(226)
|
(228)
|
(243)
|
(251)
|
(270)
|
(289)
|
(295)
|
(301)
|
(298)
|
(305)
|
(301)
|
(303)
|
(325)
|
(339)
|
(373)
|
(375)
|
(370)
|
(360)
|
(365)
|
(335)
|
(293)
|
(236)
|
(190)
|
(151)
|
(130)
|
(122)
|
(119)
|
(118)
|
(111)
|
|
Selling, General & Administrative |
(36)
|
(48)
|
(53)
|
(62)
|
(72)
|
(74)
|
(83)
|
(88)
|
(90)
|
(92)
|
(91)
|
(88)
|
(85)
|
(82)
|
(86)
|
(86)
|
(96)
|
(99)
|
(100)
|
(101)
|
(97)
|
(98)
|
(95)
|
(99)
|
(106)
|
(108)
|
(110)
|
(112)
|
(109)
|
(113)
|
(114)
|
(108)
|
(101)
|
(87)
|
(77)
|
(72)
|
(67)
|
(68)
|
(71)
|
(71)
|
(70)
|
|
Research & Development |
(121)
|
(137)
|
(153)
|
(159)
|
(169)
|
(163)
|
(147)
|
(139)
|
(129)
|
(129)
|
(131)
|
(132)
|
(142)
|
(147)
|
(158)
|
(165)
|
(174)
|
(181)
|
(187)
|
(200)
|
(201)
|
(207)
|
(205)
|
(204)
|
(219)
|
(232)
|
(248)
|
(263)
|
(260)
|
(263)
|
(251)
|
(228)
|
(192)
|
(149)
|
(113)
|
(79)
|
(63)
|
(54)
|
(49)
|
(47)
|
(41)
|
|
Other Operating Expenses |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(15)
|
0
|
0
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(156)
N/A
|
(184)
-18%
|
(202)
-10%
|
(210)
-4%
|
(233)
-11%
|
(210)
+10%
|
(199)
+5%
|
(193)
+3%
|
(182)
+6%
|
(186)
-2%
|
(188)
-1%
|
(178)
+5%
|
(181)
-1%
|
(198)
-9%
|
(215)
-9%
|
(239)
-11%
|
(260)
-9%
|
(274)
-5%
|
(258)
+6%
|
(255)
+1%
|
(239)
+6%
|
(248)
-4%
|
(241)
+3%
|
(244)
-1%
|
(252)
-3%
|
(251)
+0%
|
(296)
-18%
|
(292)
+1%
|
(298)
-2%
|
(294)
+1%
|
(301)
-3%
|
(276)
+8%
|
(238)
+14%
|
(182)
+24%
|
(138)
+24%
|
(100)
+28%
|
(79)
+21%
|
(73)
+8%
|
(68)
+7%
|
(63)
+7%
|
(53)
+15%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
(0)
|
(1)
|
(2)
|
(4)
|
(4)
|
(3)
|
(1)
|
3
|
13
|
14
|
16
|
14
|
10
|
14
|
22
|
24
|
(4)
|
(5)
|
(4)
|
11
|
(7)
|
(14)
|
(26)
|
(43)
|
2
|
7
|
9
|
9
|
7
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(16)
|
0
|
(16)
|
0
|
0
|
16
|
14
|
(20)
|
(30)
|
(33)
|
(34)
|
(16)
|
(10)
|
(8)
|
(4)
|
(3)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(156)
N/A
|
(184)
-18%
|
(202)
-10%
|
(210)
-4%
|
(231)
-10%
|
(208)
+10%
|
(197)
+5%
|
(190)
+3%
|
(181)
+5%
|
(185)
-2%
|
(187)
-1%
|
(178)
+5%
|
(181)
-2%
|
(199)
-10%
|
(218)
-9%
|
(251)
-15%
|
(272)
-8%
|
(277)
-2%
|
(258)
+7%
|
(253)
+2%
|
(226)
+10%
|
(234)
-3%
|
(226)
+3%
|
(230)
-2%
|
(242)
-5%
|
(252)
-4%
|
(275)
-9%
|
(285)
-3%
|
(303)
-6%
|
(300)
+1%
|
(290)
+3%
|
(251)
+13%
|
(265)
-5%
|
(225)
+15%
|
(196)
+13%
|
(176)
+10%
|
(93)
+47%
|
(76)
+19%
|
(67)
+11%
|
(59)
+13%
|
(49)
+16%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
(2)
|
(7)
|
(6)
|
(11)
|
(12)
|
(11)
|
(1)
|
3
|
6
|
9
|
(10)
|
(15)
|
(15)
|
(15)
|
(14)
|
(9)
|
(1)
|
0
|
11
|
11
|
4
|
9
|
5
|
5
|
6
|
(0)
|
9
|
9
|
9
|
9
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(3)
|
(6)
|
|
Income from Continuing Operations |
(156)
|
(184)
|
(203)
|
(217)
|
(237)
|
(220)
|
(209)
|
(202)
|
(182)
|
(182)
|
(182)
|
(168)
|
(191)
|
(214)
|
(233)
|
(266)
|
(285)
|
(285)
|
(260)
|
(252)
|
(216)
|
(223)
|
(222)
|
(221)
|
(237)
|
(247)
|
(270)
|
(285)
|
(295)
|
(291)
|
(281)
|
(243)
|
(265)
|
(226)
|
(196)
|
(177)
|
(93)
|
(75)
|
(68)
|
(61)
|
(55)
|
|
Net Income (Common) |
(156)
N/A
|
(184)
-18%
|
(203)
-10%
|
(217)
-7%
|
(237)
-9%
|
(220)
+7%
|
(209)
+5%
|
(202)
+3%
|
(182)
+10%
|
(182)
+0%
|
(182)
+0%
|
(168)
+7%
|
(191)
-13%
|
(214)
-12%
|
(233)
-9%
|
(266)
-14%
|
(285)
-7%
|
(285)
+0%
|
(260)
+9%
|
(252)
+3%
|
(216)
+15%
|
(223)
-3%
|
(222)
+0%
|
(221)
+0%
|
(237)
-7%
|
(247)
-4%
|
(270)
-9%
|
(285)
-6%
|
(278)
+3%
|
(275)
+1%
|
(264)
+4%
|
(226)
+15%
|
(199)
+12%
|
(146)
+27%
|
(101)
+30%
|
851
N/A
|
872
+3%
|
876
+0%
|
869
-1%
|
(57)
N/A
|
(55)
+3%
|
|
EPS (Diluted) |
-4.84
N/A
|
-5.7
-18%
|
-6.39
-12%
|
-6.81
-7%
|
-7.46
-10%
|
-6.57
+12%
|
-6.23
+5%
|
-5.98
+4%
|
-5.34
+11%
|
-4.74
+11%
|
-4.08
+14%
|
-3.61
+12%
|
-4.26
-18%
|
-4.14
+3%
|
-4.45
-7%
|
-5.05
-13%
|
-5.45
-8%
|
-5.35
+2%
|
-4.82
+10%
|
-4.65
+4%
|
-3.99
+14%
|
-4.06
-2%
|
-4
+1%
|
-3.95
+1%
|
-4.25
-8%
|
-4.14
+3%
|
-4.29
-4%
|
-4.5
-5%
|
-4.46
+1%
|
-4.25
+5%
|
-4.01
+6%
|
-3.06
+24%
|
-2.86
+7%
|
-1.93
+33%
|
-1.32
+32%
|
11.26
N/A
|
11.84
+5%
|
13.92
+18%
|
15.31
+10%
|
-1.08
N/A
|
-1
+7%
|